ASX:IDX

Integral Diagnostics Limited (IDX.AX) Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range

A$3.31

MA: A$3.31▼

A$3.31

52-Week Range N/A

Volume240,828 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend Yield1.90%

BetaN/A

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company provides its services through 64 radiology clinics, including 20 hospital sites. Integral Diagnostics Limited was incorporated in 2008 and is headquartered in Melbourne, Australia.

Overall MarketRank^™

0.83 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Integral Diagnostics Limited (IDX.AX).

2.5 Community Rank

Outperform Votes
Integral Diagnostics Limited (IDX.AX) has received 14 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Integral Diagnostics Limited (IDX.AX) has received 14 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Integral Diagnostics Limited (IDX.AX) has received 50.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Integral Diagnostics Limited (IDX.AX) and other stocks. Vote “Outperform” if you believe IDX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IDX will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
Integral Diagnostics Limited (IDX.AX) pays a meaningful dividend of 1.90%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Integral Diagnostics Limited (IDX.AX) does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Integral Diagnostics Limited (IDX.AX) is 65.04%. This payout ratio is at a healthy, sustainable level, below 75%.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Integral Diagnostics Limited (IDX.AX) insiders have sold more of their company's stock than they have bought. Specifically, they have bought A$0.00 in company stock and sold A$265,500.00 in company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange ASX

Industry Diagnostics & Research

Sub-IndustryN/A

SectorMedical

Current SymbolASX:IDX

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.integraldiagnostics.com.au

Phone61 3 5339 0704

EmployeesN/A

Debt

Debt-to-Equity Ratio121.69

Current Ratio1.10

Quick Ratio1.04

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$275.57 million

Price / Sales0.00

Cash FlowN/A

Price / Cash Flow23.99

Book ValueA$1.17 per share

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Receive IDX News and Ratings via Email

Sign-up to receive the latest news and ratings for IDX and its competitors with MarketBeat's FREE daily newsletter.

Integral Diagnostics Limited (IDX.AX) (ASX:IDX) Frequently Asked Questions

What stocks does MarketBeat like better than Integral Diagnostics Limited (IDX.AX)?

Wall Street analysts have given Integral Diagnostics Limited (IDX.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Integral Diagnostics Limited (IDX.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How often does Integral Diagnostics Limited (IDX.AX) pay dividends? What is the dividend yield for Integral Diagnostics Limited (IDX.AX)?

Integral Diagnostics Limited (IDX.AX) declared a Final dividend on Wednesday, August 26th. Investors of record on Thursday, October 1st will be given a dividend of 0.04 per share on Thursday, October 1st. This represents a yield of 0.93%. The ex-dividend date is Friday, August 28th.
View Integral Diagnostics Limited (IDX.AX)'s dividend history.

Is Integral Diagnostics Limited (IDX.AX) a good dividend stock?

Integral Diagnostics Limited (IDX.AX) pays an annual dividend of A$0.08 per share and currently has a dividend yield of 1.90%. The dividend payout ratio of Integral Diagnostics Limited (IDX.AX) is 65.04%. This payout ratio is at a healthy, sustainable level, below 75%.
View Integral Diagnostics Limited (IDX.AX)'s dividend history.

Who are some of Integral Diagnostics Limited (IDX.AX)'s key competitors?

Some companies that are related to Integral Diagnostics Limited (IDX.AX) include (BUX) (BUX), 12144 (IME), BARD1 Life Sciences Limited (BD1.AX) (BD1), Charles River Laboratories International (CRL), Cryosite Limited (CTE.AX) (CTE), dorsaVi Ltd (DVL.AX) (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures Limited (GSS.AX) (GSS), Genetic Technologies Limited (GTG.AX) (GTG), Imagion Biosystems Limited (IBX.AX) (IBX), Lifespot Health Ltd (LSH.AX) (LSH), Medical Imaging (MEDD), OncoSil Medical Limited (OSL.AX) (OSL) and Parallax Health Sciences (PRLX).
View all of IDX's competitors.

What other stocks do shareholders of Integral Diagnostics Limited (IDX.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integral Diagnostics Limited (IDX.AX) investors own include Gevo (GEVO), Fluidigm (FLDM), EML Payments Limited (EML.AX) (EML), electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Chimerix (CMRX), Capricor Therapeutics (CAPR), Bathurst Resources Limited (BRL.AX) (BRL) and Athersys (ATHX).

Who are Integral Diagnostics Limited (IDX.AX)'s key executives?

Integral Diagnostics Limited (IDX.AX)'s management team includes the following people:

Dr. Ian Kadish M.B.A., MBBCh, MBA, CEO, MD & Director (Age 57, Pay $804.61k)
Ms. Anne Lockwood, CFO & Chief Commercial Officer
Dr. Chien Ping Ho, Exec. Director
Dr. Jacqueline Milne MBBS, Exec. Director
Mr. Paul McCrow, Chief Operating Officer
Ms. Kirsty Lally B.Com., C.A., Company Sec.

What is Integral Diagnostics Limited (IDX.AX)'s stock symbol?

Integral Diagnostics Limited (IDX.AX) trades on the ASX under the ticker symbol "IDX."

How big of a company is Integral Diagnostics Limited (IDX.AX)?

Integral Diagnostics Limited (IDX.AX) has a market capitalization of $0.00 and generates $275.57 million in revenue each year. Integral Diagnostics Limited (IDX.AX) employs 1,149 workers across the globe.

What is Integral Diagnostics Limited (IDX.AX)'s official website?

The official website for Integral Diagnostics Limited (IDX.AX) is www.integraldiagnostics.com.au.

How can I contact Integral Diagnostics Limited (IDX.AX)?

The company can be reached via phone at 61 3 5339 0704.

This page was last updated on 1/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Integral Diagnostics Limited (IDX.AX) Stock Forecast, Price & News

Adding

Adding

Adding Integral Diagnostics Limited (IDX.AX)

MarketRank™

Overall MarketRank™